FDA Inspection 1325654 — NewYork-Presbyterian Columbia Irving Medical Center

NewYork-Presbyterian Columbia Irving Medical Center — FEI 2474233

The FDA completed an inspection of NewYork-Presbyterian Columbia Irving Medical Center on Jul 2, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 2, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.